Low birth weight (LBW) is associated with increased future risk of insulin resistance and type 2 diabetes mellitus. The underlying molecular mechanisms remain poorly understood. We have previously shown that young LBW men have reduced skeletal muscle expression of PI3K p85alpha regulatory subunit and p110beta catalytic subunit, PKCzeta and GLUT4 in the fasting state. The aim of this study was to determine whether insulin activation of the PI3K/Akt and MAPK signalling pathways is altered in skeletal muscle of young adult men with LBW.Vastus lateralis muscle biopsies were obtained from 20 healthy 19-yr old men with BW< or = 10th percentile for gestational age (LBW) and 20 normal birth weight controls (NBW), matched for physical fitness and wh...
In humans with obesity or type 2 diabetes, insulin target tissues are resistant to many actions of i...
Background: Individuals born with low birth weight (LBW) have an increased risk of metabolic disease...
OBJECTIVE—Phosphoinositide 3-kinase (PI3K) is a major ef-fector in insulin signaling. rs361072, loca...
BACKGROUND: Low birth weight (LBW) is associated with increased future risk of insulin resistance an...
Low birth weight (LBW) is associated with increased future risk of insulin resistance and type 2 dia...
Aims/hypothesis Insulin resistance in skeletal muscle is a key factor in the development of type 2 d...
Insulin resistance (IR), an impaired cellular, tissue and whole body response to insulin, is a major...
Individuals with intrauterine growth retardation (IUGR) are prone to insulin resistance, whereas the...
Background: Being born with low birth weight (LBW) is a risk factor for muscle insulin resistance an...
OBJECTIVE-Phosphoinositide 3-kinase (PI3K) is a major effector in insulin signaling. rs361072, locat...
Impaired glucose tolerance (IGT) is characterized by insulin resistance. Recently, defects in the in...
Insulin resistance during pregnancy provokes gesta-tional diabetes mellitus (GDM); however, the cell...
Finnish-specific gene variant p.P50T/AKT2 (minor allele frequency (MAF) = 1.1%) is associated with i...
Studies of animal models of type 2 diabetes mellitus implicate that impaired insulin signal transduc...
BackgroundThe pathogenesis of insulin resistance in the absence of obesity is unknown. In obesity, m...
In humans with obesity or type 2 diabetes, insulin target tissues are resistant to many actions of i...
Background: Individuals born with low birth weight (LBW) have an increased risk of metabolic disease...
OBJECTIVE—Phosphoinositide 3-kinase (PI3K) is a major ef-fector in insulin signaling. rs361072, loca...
BACKGROUND: Low birth weight (LBW) is associated with increased future risk of insulin resistance an...
Low birth weight (LBW) is associated with increased future risk of insulin resistance and type 2 dia...
Aims/hypothesis Insulin resistance in skeletal muscle is a key factor in the development of type 2 d...
Insulin resistance (IR), an impaired cellular, tissue and whole body response to insulin, is a major...
Individuals with intrauterine growth retardation (IUGR) are prone to insulin resistance, whereas the...
Background: Being born with low birth weight (LBW) is a risk factor for muscle insulin resistance an...
OBJECTIVE-Phosphoinositide 3-kinase (PI3K) is a major effector in insulin signaling. rs361072, locat...
Impaired glucose tolerance (IGT) is characterized by insulin resistance. Recently, defects in the in...
Insulin resistance during pregnancy provokes gesta-tional diabetes mellitus (GDM); however, the cell...
Finnish-specific gene variant p.P50T/AKT2 (minor allele frequency (MAF) = 1.1%) is associated with i...
Studies of animal models of type 2 diabetes mellitus implicate that impaired insulin signal transduc...
BackgroundThe pathogenesis of insulin resistance in the absence of obesity is unknown. In obesity, m...
In humans with obesity or type 2 diabetes, insulin target tissues are resistant to many actions of i...
Background: Individuals born with low birth weight (LBW) have an increased risk of metabolic disease...
OBJECTIVE—Phosphoinositide 3-kinase (PI3K) is a major ef-fector in insulin signaling. rs361072, loca...